NANOGP11

Across TCGA pan-cancer cohorts, NANOGP11 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated NANOGP11 data layer.

The strongest signal is observed in thymoma (THYM), where higher NANOGP11 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NANOGP11 expression acts as an unfavorable survival marker.

THYM, BLCA, and KIRC are the cancer types where NANOGP11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.549	0.968	<.001	54	view →
BLCA	OS	Tertile	All	0.225	0.686	.047	18	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
PAAD	OS	Tertile	All	0.132	0.640	.018	18	view →
ACC	DFS	Tertile	III,IV	0.048	0.457	.015	18	view →
LUAD	DFS	Tertile	III,IV	0.206	0.670	.015	18	view →
ESCA	DFS	Tertile	All	0.240	0.776	.027	18	view →
KIRP	OS	Tertile	II,III,IV	0.536	0.866	.033	12	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	9	view →
SKCM	OS	Tertile	All	0.333	0.780	.046	9	view →
LAML	DFS	Median	All	0.397	0.649	.017	8	view →
BRCA	DFS	Tertile	II,III,IV	0.808	0.943	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

NANOGP11–THYM (OS)

Open the THYM breakdown →